Top compounds associated with response to LYPLA2


Feature Type Standardized
Nominal ANOVA
mRNA Imatinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.11 0.002
mRNA Y-39983 GDSC1000 pan-cancer AAC -0.095 0.003
mRNA masitinib GDSC1000 pan-cancer AAC -0.095 0.003
mRNA PI-103 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.087 0.004
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA PD318088 CTRPv2 pan-cancer AAC 0.099 0.005
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.005
Download CSV